UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046559
Receipt number R000053120
Scientific Title The survey of the index of arterial sitffness to predict the progression of aortic aneurysm
Date of disclosure of the study information 2022/03/01
Last modified on 2023/09/22 15:52:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The survey of the index of arterial sitffness to predict the progression of aortic aneurysm

Acronym

The survey of the index of arterial sitffness to predict the progression of aortic aneurysm

Scientific Title

The survey of the index of arterial sitffness to predict the progression of aortic aneurysm

Scientific Title:Acronym

The survey of the index of arterial sitffness to predict the progression of aortic aneurysm

Region

Japan


Condition

Condition

Aortic aneurysm

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To predict the pregression of abdominal aortic aneurysm

Basic objectives2

Others

Basic objectives -Others

To predict thorathic aortic aneurysm and aortic dissection

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The diagnosis of aortic aneurysm

Key secondary outcomes

Cardiovascular events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients underwent CAVI or other vascular tests at outpatient clinic

Key exclusion criteria

Aortitis, other aortic disease

Target sample size

7000


Research contact person

Name of lead principal investigator

1st name Nobuyuki
Middle name
Last name Masaki

Organization

National Defense Medical College

Division name

Intensive Care Medicine

Zip code

359-8513

Address

3-2 Namiki, Tokorozawa,Saitama

TEL

+81429951211

Email

masakinobuyuki@hotmail.com


Public contact

Name of contact person

1st name Nobuyuki
Middle name
Last name Masaki

Organization

National Defense Medical College

Division name

Intensive Care Medicine

Zip code

359-8513

Address

3-2 Namiki, Tokorozawa,Saitama

TEL

+81429951211

Homepage URL


Email

masakinobuyuki@hotmail.com


Sponsor or person

Institute

National Defense Medical College,Intensive Care Medicine

Institute

Department

Personal name



Funding Source

Organization

National Defense Medical College,Intensive Care Medicine

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Defense Medical College,Intensive Care Medicine

Address

3-2 Namiki, Tokorozawa,Saitama

Tel

+81429951211

Email

masakinobuyuki@hotmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 01 Month 06 Day

Date of IRB

2022 Year 02 Month 01 Day

Anticipated trial start date

2022 Year 03 Month 01 Day

Last follow-up date

2026 Year 03 Month 01 Day

Date of closure to data entry

2027 Year 03 Month 01 Day

Date trial data considered complete

2027 Year 03 Month 01 Day

Date analysis concluded

2030 Year 03 Month 01 Day


Other

Other related information

Other vascular physiological tests will be added if they seem promising.


Management information

Registered date

2022 Year 01 Month 06 Day

Last modified on

2023 Year 09 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053120